The_DT
PEBP2betaMYH11_NN
fusion_NN
created_VBN
by_IN
Inv_NNP
16_CD
-LRB-_-LRB-
p13_NN
;_:
q22_NN
-RRB-_-RRB-
in_IN
myeloid_JJ
leukemia_NN
impairs_VBZ
neutrophil_NN
maturation_NN
and_CC
contributes_VBZ
to_TO
granulocytic_JJ
dysplasia_NN
._.

Chromosomal_JJ
translocations_NNS
involving_VBG
the_DT
genes_NNS
encoding_VBG
the_DT
alpha_NN
and_CC
beta_NN
subunits_NNS
of_IN
the_DT
Pebp2\/Cbf_NN
transcription_NN
factor_NN
have_VBP
been_VBN
associated_VBN
with_IN
human_JJ
acute_JJ
myeloid_JJ
leukemia_NN
and_CC
the_DT
preleukemic_JJ
condition_NN
,_,
myelodysplasia_NN
._.

Inv_NN
16_CD
-LRB-_-LRB-
p13_NN
;_:
q22_NN
-RRB-_-RRB-
fuses_VBZ
the_DT
gene_NN
encoding_VBG
the_DT
beta_NN
subunit_NN
of_IN
Pebp2_NN
to_TO
the_DT
MYH11_NN
gene_NN
encoding_VBG
a_DT
smooth_JJ
muscle_NN
myosin_JJ
heavy_JJ
chain_NN
-LRB-_-LRB-
Smmhc_NN
-RRB-_-RRB-
._.

To_TO
examine_VB
the_DT
effect_NN
of_IN
the_DT
inv_NN
16_NN
-LRB-_-LRB-
p13_NN
;_:
q22_NN
-RRB-_-RRB-
on_IN
myelopoiesis_NN
,_,
we_PRP
used_VBD
the_DT
hMRP8_NN
promoter_NN
element_NN
to_TO
generate_VB
transgenic_JJ
mice_NNS
expressing_VBG
the_DT
Pebp2beta_NN
Smmhc_NN
chimeric_JJ
fusion_NN
protein_NN
in_IN
myeloid_JJ
cells_NNS
._.

Neutrophil_NN
maturation_NN
was_VBD
impaired_JJ
in_IN
PEBP2betaMYH11_NN
transgenic_JJ
mice_NNS
._.

Although_IN
the_DT
transgenic_JJ
mice_NNS
had_VBD
normal_JJ
numbers_NNS
of_IN
circulating_VBG
neutrophils_NNS
,_,
their_PRP$
bone_NN
marrow_NN
contained_VBD
increased_VBN
numbers_NNS
of_IN
immature_JJ
neutrophilic_JJ
cells_NNS
,_,
which_WDT
exhibited_VBD
abnormal_JJ
characteristics_NNS
._.

In_IN
addition_NN
,_,
PEBP2betaMYH11_NN
inhibited_VBD
neutrophilic_JJ
differentiation_NN
in_IN
colonies_NNS
derived_VBN
from_IN
hematopoietic_JJ
progenitors_NNS
._.

Coexpression_NN
of_IN
both_CC
PEBP2betaMYH11_NN
and_CC
activated_VBN
NRAS_NNS
induced_VBD
a_DT
more_RBR
severe_JJ
phenotype_NN
characterized_VBN
by_IN
abnormal_JJ
nuclear_JJ
morphology_NN
indicative_NN
of_IN
granulocytic_JJ
dysplasia_NN
._.

These_DT
results_NNS
show_VBP
that_IN
PEBP2betaMYH11_NN
can_MD
impair_VB
neutrophil_NN
development_NN
and_CC
provide_VBP
evidence_NN
that_IN
alterations_NNS
of_IN
Pebp2_NN
can_MD
contribute_VB
to_TO
the_DT
genesis_NN
of_IN
myelodysplasia_NN
._.

